
### [MONDO:0017343](http://purl.obolibrary.org/obo/MONDO_0017343)
**Label:** Epstein-Barr virus-associated malignant lymphoproliferative disorder

**Subclasses:** [MONDO:0017347](http://purl.obolibrary.org/obo/MONDO_0017347) (Plasmablastic lymphoma), [MONDO:0020328](http://purl.obolibrary.org/obo/MONDO_0020328) (classic Hodgkin lymphoma, mixed cellularity type), [MONDO:0017346](http://purl.obolibrary.org/obo/MONDO_0017346) (Epstein-Barr virus-positive diffuse large b-cell lymphoma of the elderly), [MONDO:0020329](http://purl.obolibrary.org/obo/MONDO_0020329) (classic Hodgkin lymphoma, lymphocyte-rich type), [MONDO:0018842](http://purl.obolibrary.org/obo/MONDO_0018842) (primary effusion lymphoma), [MONDO:0018732](http://purl.obolibrary.org/obo/MONDO_0018732) (primary central nervous system lymphoma), [MONDO:0017601](http://purl.obolibrary.org/obo/MONDO_0017601) (diffuse large b-cell lymphoma with chronic inflammation), [MONDO:0018224](http://purl.obolibrary.org/obo/MONDO_0018224) (hydroa vacciniforme-like lymphoma), [MONDO:0019478](http://purl.obolibrary.org/obo/MONDO_0019478) (nodular lymphocyte predominant Hodgkin lymphoma), [MONDO:0010273](http://purl.obolibrary.org/obo/MONDO_0010273) (lymphoma, Hodgkin, X-linked pseudoautosomal), [MONDO:0018223](http://purl.obolibrary.org/obo/MONDO_0018223) (systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood), [MONDO:0019466](http://purl.obolibrary.org/obo/MONDO_0019466) (lymphomatoid granulomatosis), [MONDO:0019472](http://purl.obolibrary.org/obo/MONDO_0019472) (extranodal nasal NK/T cell lymphoma), [MONDO:0019088](http://purl.obolibrary.org/obo/MONDO_0019088) (Post-transplant lymphoproliferative disease), [MONDO:0009348](http://purl.obolibrary.org/obo/MONDO_0009348) (classic Hodgkin lymphoma), [MONDO:0020327](http://purl.obolibrary.org/obo/MONDO_0020327) (classic Hodgkin lymphoma, nodular sclerosis type), [MONDO:0004952](http://purl.obolibrary.org/obo/MONDO_0004952) (Hodgkins lymphoma), [MONDO:0020330](http://purl.obolibrary.org/obo/MONDO_0020330) (classic Hodgkin lymphoma, lymphocyte-depleted type), [MONDO:0007243](http://purl.obolibrary.org/obo/MONDO_0007243) (Burkitts lymphoma), [MONDO:0010762](http://purl.obolibrary.org/obo/MONDO_0010762) (lymphoma, Hodgkin, Y-linked pseudoautosomal), 

**Corr. equiv. classes:** [Orphanet:86869](http://www.orpha.net/ORDO/Orphanet_86869), [Orphanet:300888](http://www.orpha.net/ORDO/Orphanet_300888), [Orphanet:86879](http://www.orpha.net/ORDO/Orphanet_86879), [Orphanet:98293](http://www.orpha.net/ORDO/Orphanet_98293), [OMIM:300221](http://purl.obolibrary.org/obo/OMIM_300221), [Orphanet:364033](http://www.orpha.net/ORDO/Orphanet_364033), [Orphanet:48686](http://www.orpha.net/ORDO/Orphanet_48686), [Orphanet:46135](http://www.orpha.net/ORDO/Orphanet_46135), [Orphanet:289666](http://www.orpha.net/ORDO/Orphanet_289666), [Orphanet:391](http://www.orpha.net/ORDO/Orphanet_391), [Orphanet:364039](http://www.orpha.net/ORDO/Orphanet_364039), [Orphanet:86893](http://www.orpha.net/ORDO/Orphanet_86893), [OMIM:113970](http://purl.obolibrary.org/obo/OMIM_113970), [Orphanet:289661](http://www.orpha.net/ORDO/Orphanet_289661), [Orphanet:70568](http://www.orpha.net/ORDO/Orphanet_70568), [Orphanet:98843](http://www.orpha.net/ORDO/Orphanet_98843), [Orphanet:98844](http://www.orpha.net/ORDO/Orphanet_98844), [Orphanet:98845](http://www.orpha.net/ORDO/Orphanet_98845), [Orphanet:98846](http://www.orpha.net/ORDO/Orphanet_98846), [OMIM:400021](http://purl.obolibrary.org/obo/OMIM_400021), [Orphanet:543](http://www.orpha.net/ORDO/Orphanet_543), [OMIM:236000](http://purl.obolibrary.org/obo/OMIM_236000), 

**Class expressions from DL-Learner:**

- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology))) 35.63%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0000152](http://purl.obolibrary.org/obo/HP_0000152) (Abnormality of head or neck))) 35.63%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0000234](http://purl.obolibrary.org/obo/HP_0000234) (Abnormality of the head))) 35.29%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face))) 34.96%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) 28.27%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 23.27%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 23.11%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 23.07%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 20.52%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 20.39%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 20.29%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 20.18%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 19.89%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 19.37%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 17.26%


